{
    "clinical_study": {
        "@rank": "45228", 
        "acronym": "PAFOS", 
        "arm_group": [
            {
                "arm_group_label": "AF Suppression On", 
                "arm_group_type": "Active Comparator", 
                "description": "AF Suppression Algorithm On, optimized AF Pacemaker Programming"
            }, 
            {
                "arm_group_label": "AF Suppression Off", 
                "arm_group_type": "Active Comparator", 
                "description": "AF Suppression programmed Off, Optimized Pacemaker Programming"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluation of dynamic Atrial Overdrive Stimulation using the AF Suppression Algorithm to\n      prevent atrial tachyarrhythmias in patients with more than 2% Auto Mode Switch Episodes with\n      optimized pacemaker programming.\n\n      Hypothesis:\n\n      Dynamic atrial Overdrive (AF Suppression) reduces AT/AF Burden by 30% as compared to\n      programming DDDR-(60) without AF Suppression when all other parameters are optimized."
        }, 
        "brief_title": "Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation", 
        "completion_date": {
            "#text": "April 2008", 
            "@type": "Actual"
        }, 
        "condition": [
            "Bradycardia", 
            "Atrial Fibrillation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Bradycardia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Atrial Fibrillation is the most common Heart Rhythm Disorder requiring therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  indication for dual chamber pacemaker\n\n          -  documented paroxysmal or persistent Atrial Fibrillation\n\n          -  P-wave >1.0 mV in Sinus Rhythm or sufficient detection of AFib\n\n          -  stable antyarrhythmic therapy\n\n          -  age >= 19 years\n\n          -  written informed consent\n\n          -  implantation of a Identity DR 5370/5376 or later\n\n          -  bipolar atrial lead\n\n        Exclusion Criteria:\n\n          -  permanent AFib\n\n          -  reversible etiology of AFib\n\n          -  HYHA II or IV\n\n          -  Coronary Artery disease with stable angina pectoris\n\n          -  implanted ICD or planned implantation of a ICD\n\n          -  cardiac surgery within the last 6 months or planned within 12 months\n\n          -  live expectancy < 12 months\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "249", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01912326", 
            "org_study_id": "B01- 408"
        }, 
        "intervention": {
            "arm_group_label": [
                "AF Suppression On", 
                "AF Suppression Off"
            ], 
            "description": "Implantation of a dual chamber pacemaker", 
            "intervention_name": "Pacemaker Implantation", 
            "intervention_type": "Device", 
            "other_name": "Pacemaker St. Jude Medical Identity DR Model 5370 or 5376"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pacemaker", 
            "atrial fibrillation"
        ], 
        "lastchanged_date": "July 26, 2013", 
        "number_of_arms": "2", 
        "official_title": "Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Reduction of AT/AF Burden in the pacemaker diagnostics", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01912326"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2002", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}